Analysis of costs and cost-effectiveness of preferred GESIDA/National AIDS Plan regimens for initial antiretroviral therapy in human immunodeficiency virus infected adult patients in 2013

Autor:	Blasco, AJ, Llibre, JM, Arribas, JR, Boix, V, Clotet, B, Domingo, P, Gonzalez-Garcia, J, Knobel, H, Lopez, JC, Lozano, F, Miro, JM, Podzamczer, D, Santamaria, JM, Tuset, M, Zamora, L, Lazaro, P, Gatell, JM
Rok vydání:	2013
Předmět:	AIDS Efficacy Cost Human immunodeficiency virus Antiretrovirals Effectiveness Therapy
Zdroj:	ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau instname
ISSN:	0213-005X
Popis:	Introduction: The GESIDA and National AIDS Plan panel of experts have proposed "preferred regimens" of antiretroviral treatment (ART) as initial therapy in HIV infected patients for 2013. The objective of this study is to evaluate the costs and effectiveness of initiating treatment with these "preferred regimens". Methods: An economic assessment of costs and effectiveness (cost/effectiveness) was performed using decision tree analysis models. Effectiveness was defined as the probability of having viral load
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::79569f156e8118cde59244af2a3941c1 https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=9558 Zobrazit plný text záznamu